Liberum Capital reissued their buy rating on shares of Tate & Lyle PLC (LON:TATE) in a research report released on Monday morning. Liberum Capital currently has a GBX 795 ($9.84) target price on the stock.
Several other equities research analysts have also commented on TATE. Jefferies Group upped their price objective on Tate & Lyle PLC from GBX 640 ($7.92) to GBX 720 ($8.91) and gave the stock a buy rating in a research report on Wednesday, June 15th. Davy Research reaffirmed a neutral rating on shares of Tate & Lyle PLC in a research note on Wednesday, June 22nd. BNP Paribas reaffirmed a neutral rating and set a GBX 640 ($7.92) target price on shares of Tate & Lyle PLC in a research note on Monday, June 27th. Societe Generale reaffirmed a buy rating on shares of Tate & Lyle PLC in a research note on Tuesday, June 28th. Finally, Goldman Sachs Group Inc. set a GBX 670 ($8.29) target price on Tate & Lyle PLC and gave the stock a neutral rating in a research note on Tuesday, June 28th. Nine equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The company has a consensus rating of Hold and a consensus price target of GBX 754.42 ($9.34).
Shares of Tate & Lyle PLC (LON:TATE) opened at 793.50 on Monday. The stock’s 50 day moving average is GBX 740.49 and its 200 day moving average is GBX 669.06. Tate & Lyle PLC has a 52-week low of GBX 529.00 and a 52-week high of GBX 800.78. The company’s market cap is GBX 3.68 billion.
In other news, insider Frederiksen,Lars bought 15,000 shares of the stock in a transaction that occurred on Monday, July 25th. The stock was bought at an average cost of GBX 699 ($8.65) per share, for a total transaction of £104,850 ($129,764.85). Also, insider Hampton,Nick sold 45,600 shares of the firm’s stock in a transaction dated Friday, August 19th. The shares were sold at an average price of GBX 739 ($9.15), for a total value of £336,984 ($417,059.41).
About Tate & Lyle PLC
Tate & Lyle PLC provides ingredients and solutions to the food, beverage and other industries. The Company operates through two business segments: Speciality Food Ingredients, which offers products, such as sweeteners, texturants, health and wellness, and food systems, and Bulk Ingredients segment, which offers products, such as liquid sweeteners, industrial starches, citric acid, bio-fuels and animal feed.
Receive News & Ratings for Tate & Lyle PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle PLC and related companies with MarketBeat.com's FREE daily email newsletter.